Comments to NIH: ODS Strategic Plan 2022-2026 Share page: CHPA appreciates the opportunity to provide comments on NIH ODS strategic plan 2022-2026. Download Document Issues: Dietary Supplements Ingredient Safety Labeling Related Posts Press Releases and Statements CHPA Statement on Senate Confirmation of Dr. Makary as FDA Commissioner Mar 25, 2025 Press Releases and Statements CHPA Expresses Serious Disappointment and Concern for Consumers Over New Law in West Virginia Banning Certain Additives in Dietary Supplements Mar 25, 2025 Press Releases and Statements CHPA Comments on News of Dismissals & Layoffs at FDA Feb 18, 2025